Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chmp
Biotech
Minoryx knocked back by EMA but vows to seek rerun of review
EMA swatted away Minoryx’s attempt to bring a rare disease candidate to market on the strength of a clinical trial that missed its primary endpoint.
Nick Paul Taylor
Jan 26, 2024 8:40am
PTC deepens layoffs as DMD drug faces loss of EU authorization
Sep 29, 2023 8:51am
Orphazyme to assess strategic options after EU advisers nix drug
Feb 24, 2022 10:45am
Sunesis slumps after pulling plug on lead drug in Europe
May 2, 2017 9:11am
XBiotech slumps on likely EMA rejection of cancer drug
Apr 21, 2017 7:19am
Blue Earth gets EMA nod for prostate cancer imaging agent
Mar 24, 2017 9:46am
